Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis (RheSolve)

Targeted Disease(s):
COPD

Purpose of Study:

This is a prospective, randomized, parallel group, double-blind, sham-controlled, multicenter clinical trial following patients to 2 years. The objective is to assess the safety and effectiveness of Bronchial Rheoplasty for the treatment of the symptoms of chronic bronchitis in adult COPD patients with moderate to severe chronic bronchitis. A total of 270 patients will be randomized at up to 40 study centers in the United States, Canada, and Europe.

Study Dates:
April 7, 2021 - January 1, 2024

Study Location:
Nationwide

Lead Institution:
University of Pittsburgh Medical Center and Karl-Landsteiner-Institute for Lung Research and Pulmonary Oncology

Funding Source:
Private

ClinicalTrails.gov Identifier:
NCT04677465

Sponosor: Gala Therapeutics, Inc.

Learn More About Trial
Freedom From Smoking Clinic
, | May 02, 2022
Freedom From Smoking Clinic
Virginia Beach, VA | May 10, 2022